948 F.3d 1330
Fed. Cir.2020Background
- The '806 patent claims a hybrid media-delivery method: a control information file lists multiple alternative files per segment and allows a client to select a compatible format and download the next file concurrently with playback of the current file.
- Claim 1 recites steps including downloading/parsing a control file, identifying alternative files for a given segment, selecting files based on system restraints, retrieving a determined file to begin playback, and—if multiple files are required—concurrently retrieving a next file and using it to continue playback.
- Relevant prior art: SMIL 1.0 (specifies alternative-file selection via a "switch" element and sequential playback via "seq") and Hua (describes pipelining: play segment Sn while downloading S(n+1)).
- Google petitioned for IPR arguing anticipation by SMIL and obviousness over SMIL (and, in argument, relying on general knowledge of pipelining); the PTAB instituted on anticipation, obviousness over SMIL, and sua sponte on obviousness over SMIL+Hua.
- The Board found claims 1–11 obvious over SMIL (and for the same reasons over SMIL+Hua). Philips appealed, contending (1) the Board unlawfully instituted an unpled ground (SMIL+Hua), (2) the Board improperly relied on general knowledge to fill a missing limitation, and (3) the obviousness findings lack substantial evidence.
- The Federal Circuit held the Board erred in instituting the SMIL+Hua ground (not in Google’s petition) but affirmed the Board’s ultimate determination that claims 1–11 are unpatentable as obvious (based on SMIL and the skilled artisan’s knowledge).
Issues
| Issue | Philips' Argument | Google's Argument | Held |
|---|---|---|---|
| Whether the PTAB may institute an IPR on a ground not pleaded in the petition (SMIL+Hua). | Board lacked authority to institute an unpled obviousness ground; petition defined the proceeding. | Board acted within discretion and only used SMIL+Hua for clarity using the same arguments/evidence. | Court: Institution on an unpled ground was error; petition, not the Board, defines the review's contours (SAS controls). |
| Whether the Board improperly relied on "general knowledge" to supply a missing claim limitation. | §311(b) limits IPR to patents/printed publications so Board cannot use general knowledge to supply limitations; reliance here echoes Arendi. | General knowledge of a skilled artisan is proper in obviousness under §103 and may supply missing limitations when supported by evidence. | Court: Using general knowledge is permissible in IPR obviousness analyses when supported by evidence; no §311(b) bar and Arendi did not preclude use here because there was corroborating expert evidence and Hua. |
| Whether substantial evidence supports the Board's obviousness finding over SMIL (and SMIL + artisan knowledge). | Board lacked substantial evidence that combining SMIL with pipelining would motivate or enable the claimed steps; reliance on patentees' specification and assumptions was improper. | Expert testimony, Hua, and the patent’s own admissions support motivation to combine, reasonable expectation of success, and enablement. | Court: Substantial evidence supports the Board's findings that a skilled artisan would combine SMIL with known pipelining, so claims 1–11 are obvious; reliance on the specification's admissions was acceptable. |
Key Cases Cited
- SAS Inst. Inc. v. Iancu, 138 S. Ct. 1348 (2018) (a petition, not the Director/PTAB, defines the contours of an IPR institution)
- KSR Int'l Co. v. Teleflex, Inc., 550 U.S. 398 (2007) (establishes obviousness framework and role of common sense/general knowledge)
- Arendi S.A.R.L. v. Apple Inc., 832 F.3d 1355 (Fed. Cir. 2016) (limits use of common sense absent reasoned analysis and evidentiary support)
- Anacor Pharm. Inc. v. Iancu, 889 F.3d 1372 (Fed. Cir. 2018) (Board may rely on evidence beyond petition to support grounds raised in petition)
- Genzyme Therapeutic Prods. v. BioMarin Pharm., 825 F.3d 1360 (Fed. Cir. 2016) (similar to Anacor re: evidence not in petition for raised grounds)
- Rambus Inc. v. Rea, 731 F.3d 1248 (Fed. Cir. 2013) (standards of review: factual findings for substantial evidence)
- Purdue Pharma L.P. v. Epic Pharma, LLC, 811 F.3d 1345 (Fed. Cir. 2016) (obviousness is a legal conclusion based on underlying factual findings)
- Dow Jones & Co. v. Ablaise Ltd., 606 F.3d 1338 (Fed. Cir. 2010) (upholding use of general knowledge to support obviousness)
- PharmaStem Therapeutics, Inc. v. ViaCell, Inc., 491 F.3d 1342 (Fed. Cir. 2007) (patent specification admissions can be relied on in obviousness analysis)
- Sirona Dental Sys. GmbH v. Institut Straumann AG, 892 F.3d 1349 (Fed. Cir. 2018) (PTAB may read the petition broadly but is not free to institute an entirely different ground)
